Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-038267
Filing Date
2011-06-29
Accepted
2011-06-29 17:23:25
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v227306_10k.htm 10-K 2023634
2 EXHIBIT 10.70 v227306_ex10-70.htm EX-10.70 185494
3 GRAPHIC ex10-70pg01.jpg GRAPHIC 238485
4 GRAPHIC ex10-70pg02.jpg GRAPHIC 214404
5 GRAPHIC ex10-70pg03.jpg GRAPHIC 181265
6 EXHIBIT 10.71 v227306_ex10-71.htm EX-10.71 155825
7 EXHIBIT 21 v227306_ex21.htm EX-21 2214
8 EXHIBIT 31.1 v227306_ex31-1.htm EX-31.1 13205
9 EXHIBIT 31.2 v227306_ex31-2.htm EX-31.2 13133
10 EXHIBIT 32.1 v227306_ex32-1.htm EX-32.1 6586
11 EXHIBIT 32.2 v227306_ex32-2.htm EX-32.2 6642
  Complete submission text file 0001144204-11-038267.txt   3281866
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 11939913
SIC: 2834 Pharmaceutical Preparations